Lobbying client

INTCRON

Bio-pharma start-up company

Filings
1
Filed by
1
Reported in-house
—
Reported by firms
—

Filings

1 filing, newest first.
Filing Filed by Amount
Registration
4th Quarter 2026
HUTTON STRATEGIES — reported

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Medical/Disease Research/Clinical Labs MED 1

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.